BNYN Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume154.32K
Average Volume (3M)0.00
Market Cap
$1.50K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-116.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,505,486,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BNYN FAQ
What was Banyan Corp.’s price range in the past 12 months?
Banyan Corp. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Banyan Corp.’s market cap?
Banyan Corp.’s market cap is $1.50K.
When is Banyan Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Banyan Corp.’s earnings last quarter?
Currently, no data Available
Is Banyan Corp. overvalued?
According to Wall Street analysts Banyan Corp.’s price is currently Overvalued.
Does Banyan Corp. pay dividends?
Banyan Corp. does not currently pay dividends.
What is Banyan Corp.’s EPS estimate?
Banyan Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Banyan Corp. have?
Banyan Corp. has 1,505,486,800 shares outstanding.
What happened to Banyan Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Banyan Corp.?
Currently, no hedge funds are holding shares in BNYN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Banyan Corp.
Banyan Corp., operating through its subsidiaries, focuses on franchising chiropractic clinics throughout North America. The company provides extensive support to its franchisees and licensees, including specialized practice development training and assistance tailored for chiropractors. Beyond its franchising activities, Banyan delivers vital diagnostic testing services. A key offering is Nerve Conduction Velocity (NCV) testing, which is administered to patients via healthcare professionals such as doctors and chiropractors. This NCV testing is instrumental in evaluating the transmission of nerve impulses, identifying irregularities within the nervous system, and supplying objective data to substantiate treatment expenses for patients and their insurance providers. Furthermore, Banyan manufactures and markets its proprietary VT3000, an advanced nerve testing system. This system is engineered for the precise diagnosis of neuropathies – conditions affecting the peripheral nerves and spinal regions – alongside nerve irritation and other forms of nervous system damage in patients. Established in 1978, Banyan Corp. maintains its headquarters in Beverly Hills, California.
Oncology Institute
―
Agilon Health
―
P3 Health Partners
―
biote
―
Mobile-health Network Solutions Class A
―